Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo

Journal of Natural Medicines

Volumn 68, Issue 1, 2014, Pages 53-62

  Cai, Yuchen ^a   Xia, Qing ^a   Luo, Rongzhen ^a   Huang, Peiyu ^a   Sun, Yueli ^a   Shi, Yanxia ^a   Jiang, Wenqi ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Berberine; Cell cycle arrest; Colorectal carcinoma; In vivo

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE; CCNB1 PROTEIN, HUMAN; CDC25C PROTEIN, HUMAN; CDK1 PROTEIN, HUMAN; CYCLIN B; CYCLIN B1; CYCLIN DEPENDENT KINASE; FLUOROURACIL; PROTEIN TYROSINE PHOSPHATASE;

ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; G2 PHASE CELL CYCLE CHECKPOINT; HT 29 CELL LINE; HUMAN; IC50; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TIME;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BERBERINE; CDC25 PHOSPHATASES; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIN B; CYCLIN B1; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; G2 PHASE CELL CYCLE CHECKPOINTS; HT29 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED BALB C; MICE, NUDE; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84893771572     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-013-0766-z     Document Type: Article

References (42)

1. Lee DU, Kang YJ, Park MK, Lee YS, Seo HG, Kim TS, Kim CH, Chang KC (2003) Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-alpha, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci 73: 1401-1402
2. Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y (2001) Cardiovascular actions of berberine. Cardiovasc Drug Rev 19:234-244
3. Kuo CL, Chi CW, Liu TY (2004) The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127-137
4. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY (2007) Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56:193-201
5. Yan D, Jin C, Xiao XH, Dong XP (2008) Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Biophys Methods 70:845-849
6. Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S (2007) Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett 17:1562-1564
7. Ho YT, Lu CC, Yang JS, Chiang JH, Li TC, Ip SW, Hsia TC, Liao CL, Lin JG, Wood WG, Chung JG (2009) Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res 29:4063-4070
8. Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M (2000) Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 148:19-25
9. Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, Wang W, Xie C, Meng J, Wang L, Wu B, Liu S, Tian D, Zhu F, He Z, Deng F, Cao Y (2009) Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase mediated Ezrin phosphorylation at threonine 567. J Biol Chem 284:27456-27466
10. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY (2010) The alkaloid berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 17:436-440
11. Hur JM, Hyun MS, Lim SY, Lee WY, Kim D (2009) The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem 107:955-964
12. Mitani N, Murakami K, Yamaura T, Ikeda T, Saiki I (2001) Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Lett 165:35-42
13. Katiyar SK, Meeran SM, Katiyar N, Akhtar S (2009) p53 cooperates berberine induced growth inhibition and apoptosis of nonsmall cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 48:24-37
14. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG (2006) Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12:21-28
15. Kheir MM, Wang Y, Hua L, Hu J, Li L, Lei F, Du L (2010) Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol 48:1105-1110
16. Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK (2011) Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E and prostaglandin E receptors. Carcinogenesis 32:86-92
17. Li-Weber M (2013) Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett 332:304-312
18. Tsang CM, Lau EP, Di K, Cheung PY, Hau PM, Ching YP, Wong YC, Cheung AL, Wan TS, Tong Y, Tsao SW, Feng Y (2009) Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 24:131-138
19. Zhang X, Gu L, Li J, Shah N, He J, Yang L, Hu Q, Zhou M (2010) Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res 70:9895-9904
20. Meeran SM, Katiyar S, Katiyar SK (2008) Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229:33-43
21. Chen TC, Lai KC, Yang JS, Liao CL, Hsia TC, Chen GW, Lin JJ, Lin HJ, Chiu TH, Tang YJ, Chung JG (2009) Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells. Int J Oncol 34:1681-1690
22. Lu B, Hu M, Liu K, Peng J (2010) Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in silico drug-target prediction. Toxicol In Vitro 24:1482-1490
23. Qin Y, Pang JY, Chen WH, Zhao ZZ, Liu L, Jiang ZH (2007) Inhibition of DNA topoisomerase I by natural and synthetic mono- and dimeric protoberberine alkaloids. Chem Biodivers 4:481-487
24. Mazzini S, Bellucci MC, Mondelli R (2003) Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide d(AAGAATTCTT)(2). Bioorg Med Chem 11:505-514
25. Qin Y, Pang JY, Chen WH, Cai Z, Jiang ZH (2006) Synthesis, DNA-binding affinities, and binding mode of berberine dimers. Bioorg Med Chem 14:25-32
26. Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB (2008) Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res 68:5370-5379
27. Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q, He B (2012) Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling. Int J Oncol 41:292-298
28. Chidambara Murthy KN, Jayaprakasha GK, Patil BS (2012) The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol 688:14-21
29. Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH (2007) Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol 81:719-728
30. Lin JG, Chung JG, Wu LT, Chen GW, Chang HL, Wang TF (1999) Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med 27:265-275
31. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H (1999) Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 2:227-233
32. Creasey WA (1979) Biochemical effects of berberine. Biochem Pharmacol 28:1081-1084
33. Cushman M, Dekow FW, Jacobsen LB (1979) Conformations, DNA binding parameters, and antileukemic activity of certain cytotoxic protoberberine alkaloids. J Med Chem 22:331-333
34. Chi CW, Chang YF, Chao TW, Chiang SH, P'eng FK, Liu WY, Liu TY (1994) Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid reception in human hepatoma HepG2 cells. Life Sci 54:2099-2107
35. Yamagishi H (1962) Interaction between nuclei acid and berberine sulfate. J Cell Biol 15:589-592
36. Krey AK, Hahn FE (1969) Berberine: complex with DNA. Science 166:755-757
37. Li XK, Motwani M, Bornmann W, Schartz GK (2000) Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting cdc2 kinase activity in human cancer cells. Mol Pharmacol 58:1287-1293
38. Xiong CY, Shi XB, Dai ZS (1989) Pharmacokinetic study of 3H-berberine in rabbits and mouse. Chin Pharmacol Bull 5:293-296
39. Pang ZG, Wang BQ, Jiang HT (1997) Study on the pharmacokinetics of berberine. Fenxi Kexue Xuebao 13:51-53
40. Zhao XZ (1989) The clinical observation of anti-arrhythmia effects of berberine and the electrophysiology of cardiac muscle. Zhonghua Xinxueguanbing Zazhi 17:159-161
41. Zhang RX (1990) Laboratory studies of berberine used alone and in combination with 1,3-bis (2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chin Med J 103:658-665
42. Iizuka N, Miyamoto K, Kayano K, Hayashi H, Tangoku A, Oka M (1998) The enhancement of cisplatin-induced antitumor activity by Kampo medicines in human esophageal cancer. J Trad Med 15:340-341